SGLT-2 inhibitors have been found to reduce myocardial oxidative stress, fibrosis, and vascular remodeling which play important roles in the pathogenesis of cardiovascular diseases [71]. The gene discussed is SLC5A2; the disease is cardiovascular disorder.